279 related articles for article (PubMed ID: 15378132)
21. Fever accentuates transmural dispersion of repolarization and facilitates development of early afterdepolarizations and torsade de pointes under long-QT Conditions.
Burashnikov A; Shimizu W; Antzelevitch C
Circ Arrhythm Electrophysiol; 2008 Aug; 1(3):202-8. PubMed ID: 19649147
[TBL] [Abstract][Full Text] [Related]
22. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes?
Medina-Ravell VA; Lankipalli RS; Yan GX; Antzelevitch C; Medina-Malpica NA; Medina-Malpica OA; Droogan C; Kowey PR
Circulation; 2003 Feb; 107(5):740-6. PubMed ID: 12578878
[TBL] [Abstract][Full Text] [Related]
23. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
Fredj S; Sampson KJ; Liu H; Kass RS
Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744
[TBL] [Abstract][Full Text] [Related]
24. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
Antzelevitch C; Sun ZQ; Zhang ZQ; Yan GX
J Am Coll Cardiol; 1996 Dec; 28(7):1836-48. PubMed ID: 8962574
[TBL] [Abstract][Full Text] [Related]
25. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
Bottino D; Penland RC; stamps A; Traebert M; Dumotier B; Georgiva A; Helmlinger G; Lett GS
Prog Biophys Mol Biol; 2006; 90(1-3):414-43. PubMed ID: 16321428
[TBL] [Abstract][Full Text] [Related]
26. A focus on antiarrhythmic properties of ranolazine.
Vizzardi E; D'Aloia A; Quinzani F; Bonadei I; Rovetta R; Bontempi L; Curnis A; Dei Cas L
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):353-6. PubMed ID: 22492919
[TBL] [Abstract][Full Text] [Related]
27. Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes.
Antzelevitch C
Europace; 2007 Sep; 9 Suppl 4(Suppl 4):iv4-15. PubMed ID: 17766323
[TBL] [Abstract][Full Text] [Related]
28. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
[TBL] [Abstract][Full Text] [Related]
29. Effects of sodium channel block with mexiletine to reverse action potential prolongation in in vitro models of the long term QT syndrome.
Sicouri S; Antzelevitch D; Heilmann C; Antzelevitch C
J Cardiovasc Electrophysiol; 1997 Nov; 8(11):1280-90. PubMed ID: 9395171
[TBL] [Abstract][Full Text] [Related]
30. Cellular basis for complex T waves and arrhythmic activity following combined I(Kr) and I(Ks) block.
Emori T; Antzelevitch C
J Cardiovasc Electrophysiol; 2001 Dec; 12(12):1369-78. PubMed ID: 11797994
[TBL] [Abstract][Full Text] [Related]
31. Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes.
Antzelevitch C
Heart Rhythm; 2005 Nov; 2(2 Suppl):S9-15. PubMed ID: 16253930
[TBL] [Abstract][Full Text] [Related]
32. Transmural dispersion of repolarization as a preclinical marker of drug-induced proarrhythmia.
Said TH; Wilson LD; Jeyaraj D; Fossa AA; Rosenbaum DS
J Cardiovasc Pharmacol; 2012 Aug; 60(2):165-71. PubMed ID: 22561361
[TBL] [Abstract][Full Text] [Related]
33. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
Shantsila E; Watson T; Lip GY
Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block.
Milberg P; Ramtin S; Mönnig G; Osada N; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
J Cardiovasc Pharmacol; 2004 Sep; 44(3):278-86. PubMed ID: 15475823
[TBL] [Abstract][Full Text] [Related]
35. New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia.
Frommeyer G; Rajamani S; Grundmann F; Stypmann J; Osada N; Breithardt G; Belardinelli L; Eckardt L; Milberg P
J Card Fail; 2012 Dec; 18(12):939-49. PubMed ID: 23207083
[TBL] [Abstract][Full Text] [Related]
36. Choice of cardiac tissue plays an important role in the evaluation of drug-induced prolongation of the QT interval in vitro in rabbit.
Lu HR; Vlaminckx E; Teisman A; Gallacher DJ
J Pharmacol Toxicol Methods; 2005; 52(1):90-105. PubMed ID: 15978848
[TBL] [Abstract][Full Text] [Related]
37. Cisapride-induced transmural dispersion of repolarization and torsade de pointes in the canine left ventricular wedge preparation during epicardial stimulation.
Di Diego JM; Belardinelli L; Antzelevitch C
Circulation; 2003 Aug; 108(8):1027-33. PubMed ID: 12912819
[TBL] [Abstract][Full Text] [Related]
38. Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade.
Jia S; Lian J; Guo D; Xue X; Patel C; Yang L; Yuan Z; Ma A; Yan GX
Br J Pharmacol; 2011 Sep; 164(2):308-16. PubMed ID: 21182492
[TBL] [Abstract][Full Text] [Related]
39. Acceleration-induced action potential prolongation and early afterdepolarizations.
Burashnikov A; Antzelevitch C
J Cardiovasc Electrophysiol; 1998 Sep; 9(9):934-48. PubMed ID: 9786074
[TBL] [Abstract][Full Text] [Related]
40. A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias.
Belardinelli L; Liu G; Smith-Maxwell C; Wang WQ; El-Bizri N; Hirakawa R; Karpinski S; Li CH; Hu L; Li XJ; Crumb W; Wu L; Koltun D; Zablocki J; Yao L; Dhalla AK; Rajamani S; Shryock JC
J Pharmacol Exp Ther; 2013 Jan; 344(1):23-32. PubMed ID: 23010360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
